Edition:
United States

Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

27.28USD
23 Sep 2016
Change (% chg)

$0.06 (+0.22%)
Prev Close
$27.22
Open
$27.24
Day's High
$27.62
Day's Low
$27.02
Volume
537,126
Avg. Vol
523,746
52-wk High
$43.63
52-wk Low
$23.59

Select another date:

Thu, Jun 9 2016

BRIEF-Acorda presents phase 1 data on Migraine drug at 58th annual meeting of American Headache Society

* There were no serious adverse events, dose limiting toxicities, study discontinuations due to adverse events reported for cvt-427

BRIEF-Biotie Therapies: final results of subsequent offer period of Acorda's tender offer

* Final results of the subsequent offer period of Acorda's tender offer for all securities in Biotie

BRIEF-Acorda announces results from mid-phase clinical trial of CVT-301

* Acorda Announces Results From Phase 2b Clinical Trial Of CVT 301 for treatment of off periods in parkinson's disease published in movement disorders

BRIEF-Acorda Therapeutics: results of tender offer for Biotie Therapies

* Says tender offer for Biotie Therapies Corp expired on April 8

Select another date: